CRSP EPS Estimates
CRISPR Therapeutics AG
$50.22
+$0.12(+0.24%)
40
Overall
60
Value
10
Tech
50
Quality
Market Cap
$4.86B
Volume
1.70M
52W Range
$44.12 - $75.16
Target Price
$85.00
CRSP EPS estimates: the consensus estimate for CRISPR Therapeutics AG's current fiscal year is -$4.47 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CRSP EPS Estimates
- EPS estimate, current quarter
- $-1.06
- EPS estimate, next quarter
- $-1.25
- EPS estimate, current year
- $-4.47
- EPS estimate, next year
- $-3.61
- EPS growth, 3-year
- +8.19%
| Fiscal year | EPS |
|---|---|
| 2025 | $-6.47 |
| 2024 | $-4.34 |
| 2023 | $-1.94 |
| 2022 | $-8.36 |
| 2021 | $4.97 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRSP | $50.22 | +0.2% | 1.70M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |